Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XTLB | US
0.19
9.60%
Healthcare
Biotechnology
01/01/1970
17/10/2024
2.17
2.18
2.18
2.16
XTL Biopharmaceuticals Ltd. a biopharmaceutical company engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1 a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research development and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan Israel.
View LessPrice Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
75.1%1 month
61.3%3 months
56.2%6 months
75.8%-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.53
Range1M
0.62
Range3M
1.08
Rel. volume
0.69
Price X volume
8.80K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc | VNDA | Biotechnology | 4.735 | 0 | -3.37% | n/a | |
Viking Therapeutics Inc | VKTX | Biotechnology | 64.615 | 0 | -1.88% | n/a | |
VIRACTA THERAPEUTICS INC | VIRX | Biotechnology | 0.2228 | 0 | -0.45% | n/a | |
VINC | VINC | Biotechnology | 0.3775 | 0 | -5.15% | n/a | |
Vigil Neuroscience Inc. Common Stock | VIGL | Biotechnology | 3.99 | 0 | 3.37% | n/a | |
Verve Therapeutics Inc. Common Stock | VERV | Biotechnology | 5.46 | 0 | -2.50% | n/a | |
Vera Therapeutics Inc. Class A Common Stock | VERA | Biotechnology | 39.89 | 0 | -0.25% | n/a | |
Veracyte Inc | VCYT | Biotechnology | 34.31 | 0 | -1.18% | n/a | |
Vaccinex Inc - Ordinary Shares | VCNX | Biotechnology | 2.52 | 0 | -3.08% | n/a | |
Vericel Corporation | VCEL | Biotechnology | 40.67 | 0 | -1.45% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a | |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 0.53 | - |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | - | 15.30 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 56.20 | 72.92 | Lower Risk |
Debt to Equity | - | -1.24 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | - | 3.78B | - |